Skip to main content
SpringerLink
Log in

Integration of a Team Approach to Hypertension Treatment

  • Chapter
  • First Online:
Hypertension in High Risk African Americans

Part of the book series: Clinical Hypertension and Vascular Diseases ((CHVD))

Abstract

Hypertension is the most common chronic cardiovascular condition encountered in outpatient and ambulatory settings. According to the American Heart Association Heart Disease Statistics 2013 update, it is estimated that 33 % of US adults have hypertension. This represents approximately 78 million American adults with hypertension. Through significant patient education and outreach, clinical management, and general greater self-awareness, the USA has seen a marked increase in the number of people that are aware of their condition. It is estimated that approximately 82 % of adult patients are aware of their hypertension condition, and approximately 75 % of adult patients are using antihypertensive medication. Despite this enhanced awareness, only 53 % of patients diagnosed with hypertension are at or below their target blood pressure goals at current recommended levels. African American awareness of hypertension has significantly improved, but the excess burden of elevated blood pressure and the subsequent consequences on health outcomes remain high. Medication nonadherence is widely recognized as a major cause of patients not maintaining control of chronic cardiovascular conditions. Other causes for patients not attaining their blood pressure goals may include socioeconomic challenges, advanced atherosclerotic vascular changes from prolonged exposure to uncontrolled cardiovascular risks, and lack of positive response to medication therapy. Despite the overall causes, the necessity to find alternative and innovative methods to adequately control hypertension in Americans remains the goal of all healthcare clinicians.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127(1):143–52.

    Article  PubMed  Google Scholar 

  2. Ngo-Metzger Q, Sorkin DH, Billimek J, Greenfield S, Kaplan SH. The effects of financial pressures on adherence and glucose control among racial/ethnically diverse patients with diabetes. J Gen Intern Med. 2012;27(4):432–7.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Burns K, Turnbull F, Patel A, Peiris D. Opinions of community pharmacists on the value of a cardiovascular polypill as a means of improving medication compliance. Int J Pharm Pract. 2012;20(3):155–63.

    Article  PubMed  Google Scholar 

  4. Hiligsmann M, Boonen A, Rabenda V, Reginster JY. The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis. Expert Rev Pharmacoecon Outcomes Res. 2012;12(2):159–66.

    Article  PubMed  Google Scholar 

  5. Kleindorfer D, Lindsell C, Alwell KA, Moomaw CJ, Woo D, Flaherty ML, et al. Patients living in impoverished areas have more severe ischemic strokes. Stroke. 2012;43(8):2055–9.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Martin KD, Roter DL, Beach MC, Carson KA, Cooper LA. Physician communication behaviors and trust among black and white patients with hypertension. Med Care. 2013;51(2):151–7.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Havranek EP, Hanratty R, Tate C, Dickinson LM, Steiner JF, Cohen G, et al. The effect of values affirmation on race-discordant patient-provider communication. Arch Intern Med. 2012;172(21):1662–7.

    Article  PubMed  Google Scholar 

  8. Abel WM, Barksdale DJ. Freedom of choice and adherence to the health regimen for African Americans with hypertension. Adv Nurs Sci. 2012;35(4):E1–8.

    Article  Google Scholar 

  9. Website AHA. 2012.

    Google Scholar 

  10. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981–97.

    Google Scholar 

  11. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting—enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342(3):145.

    Article  CAS  PubMed  Google Scholar 

  12. Wright Jr JT, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2002;288(19):2421–31.

    Article  CAS  PubMed  Google Scholar 

  13. Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-Branco M. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health Syst Pharm. 2011;68(3):241–53.

    Article  PubMed  Google Scholar 

  14. Olivier HE, Jamero D. Implementation of a hypertension clinic using a streamlined treatment algorithm. Am J Health Syst Pharm. 2012;69(8):664–7.

    Article  PubMed  Google Scholar 

  15. St. Peter WL, Farley TM, Carter BL. Role of collaborative care models including pharmacists in improving blood pressure management in chronic kidney disease patients. Curr Opin Nephrol Hypertens. 2011;20(5):498–503.

    Article  PubMed  Google Scholar 

  16. Weber CA, Ernst ME, Sezate GS, Zheng S, Carter BL. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med. 2010;170(18):1634–9.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Mason NA. Polypharmacy and medication-related complications in the chronic kidney disease patient. Curr Opin Nephrol Hypertens. 2011;20(5):492–7.

    Article  PubMed  Google Scholar 

  18. Chisholm-Burns MA, Kim Lee J, Spivey CA, Slack M, Herrier RN, Hall-Lipsy E, et al. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48(10):923–33.

    Article  PubMed  Google Scholar 

  19. Carter BL, Bosworth HB, Green BB. The hypertension team: the role of the pharmacist, nurse, and teamwork in hypertension therapy. J Clin Hypertens. 2012;14(1):51–65.

    Article  Google Scholar 

  20. Chisholm-Burns MA, Graff Zivin JS, Lee JK, Spivey CA, Slack M, Herrier RN, et al. Economic effects of pharmacists on health outcomes in the United States: a systematic review. Am J Health Syst Pharm. 2010;67(19):1624–34.

    Article  PubMed  Google Scholar 

  21. Amundson EP. Scope of practice: overly cautious or professional vigilance? S D Med. 2010;63(3):107.

    PubMed  Google Scholar 

  22. Wheeler A, Crump K, Lee M, Li L, Patel A, Yang R, et al. Collaborative prescribing: a qualitative exploration of a role for pharmacists in mental health. Res Social Adm Pharm. 2012;8(3):179–92.

    Article  PubMed  Google Scholar 

  23. Gardner D. Expanding scope of practice: inter-professional collaboration or conflict? Nurs Econ. 2010;28(4):264–6.

    PubMed  Google Scholar 

  24. Kennedy TJ, Regehr G, Baker GR, Lingard L. Preserving professional credibility: grounded theory study of medical trainees’ requests for clinical support. BMJ. 2009;338:b128.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Ross LA. Pharmacists as mid-level practitioners/providers. Ann Pharmacother. 2011;45(6):810–2.

    Article  PubMed  Google Scholar 

  26. Council on Credentialing in Pharmacy, Albanese NP, Rouse MJ. Scope of contemporary pharmacy practice: roles, responsibilities, and functions of pharmacists and pharmacy technicians. J Am Pharm Assoc (2003). 2010;50(2):e35–69.

    Google Scholar 

  27. Padiyara RS, D’Souza JJ, Rihani RS. Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group. J Manag Care Pharm. 2011;17(6):456–62.

    PubMed  Google Scholar 

  28. Schillig J, Kaatz S, Hudson M, Krol GD, Szandzik EG, Kalus JS. Clinical and safety impact of an inpatient pharmacist-directed anticoagulation service. J Hosp Med. 2011;6(6):322–8.

    Article  PubMed  Google Scholar 

  29. Giberson S, Yoder S, Lee MP. Improving patient and health system outcomes through advanced pharmacy practice. A report to the U.S. Surgeon General. Office of the Chief Pharmacist. Rockville: U.S. Public Health Service; 2011.

    Google Scholar 

  30. Sargen M, Hooker RS, Cooper RA. Gaps in the supply of physicians, advance practice nurses, and physician assistants. J Am Coll Surg. 2011;212(6):991–9.

    Article  PubMed  Google Scholar 

  31. Benjamin R. Surgeon general open letter to “Improving patient and health system outcomes through advanced pharmacy practice: a report to the surgeon general”. 2011.

    Google Scholar 

  32. AAFP. AAFP—pharmacists (position paper). 2011.

    Google Scholar 

  33. APHA. The role of the pharmacist in public health. Washington, DC: American Public Health Association; 2006.

    Google Scholar 

  34. Sommers BD, Bindman AB. New physicians, the Affordable Care Act, and the changing practice of medicine. JAMA. 2012;307(16):1697–8.

    Article  CAS  PubMed  Google Scholar 

  35. Graham MC, Graham TS. Healthcare reform: what does it mean for NPs? Nurse Pract. 2011;36(5):41–7.

    Article  PubMed  Google Scholar 

  36. Davis K, Abrams M, Stremikis K. How the Affordable Care Act will strengthen the nation's primary care foundation. J Gen Intern Med. 2011;26(10):1201–3.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Poghosyan L, Lucero R, Rauch L, Berkowitz B. Nurse practitioner workforce: a substantial supply of primary care providers. Nurs Econ. 2012;30(5):268. 74, 294.

    PubMed  Google Scholar 

  38. Terhune KP, Abumrad NN. Physician shortages and our increasing dependence on the international medical graduate: is there a mutually beneficial solution? J Surg Educ. 2009;66(1):51–7.

    Article  PubMed  Google Scholar 

  39. Shannon SC, Ferretti SM, Wood D, Levitan T. The challenges of primary care and innovative responses in osteopathic education. Health Aff. 2010;29(5):1015–22.

    Article  Google Scholar 

  40. Schmidt LA, Rittenhouse DR, Wu KJ, Wiley JA. Transforming primary care in the New Orleans safety-net: the patient experience. Med Care. 2013;51(2):158–64.

    Article  PubMed  Google Scholar 

  41. Ladhani NN, Majumdar SR, Johnson JA, Tsuyuki RT, Lewanczuk RZ, Spooner R, et al. Adding pharmacists to primary care teams reduces predicted long-term risk of cardiovascular events in type 2 diabetic patients without established cardiovascular disease: results from a randomized trial. Diabet Med. 2012;29(11):1433–9.

    Article  CAS  PubMed  Google Scholar 

  42. Choe HM, Farris KB, Stevenson JG, Townsend K, Diez HL, Remington TL, et al. Patient-centered medical home: developing, expanding, and sustaining a role for pharmacists. Am J Health Syst Pharm. 2012;69(12):1063–71.

    Article  PubMed  Google Scholar 

  43. Abramowitz PW. Achieving provider status for pharmacists. Am J Health Syst Pharm. 2013;70(3):184.

    Article  PubMed  Google Scholar 

  44. Fontaine P, Flottemesch TJ, Solberg LI, Asche SE. Is consistent primary care within a patient-centered medical home related to utilization patterns and costs? J Ambul Care Manage. 2011;34(1):10–9.

    Article  PubMed  Google Scholar 

  45. Nocon RS, Sharma R, Birnberg JM, Ngo-Metzger Q, Lee SM, Chin MH. Association between patient-centered medical home rating and operating cost at federally funded health centers. JAMA. 2012;308(1):60–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Longworth DL. Accountable care organizations, the patient-centered medical home, and health care reform: what does it all mean? Cleve Clin J Med. 2011;78(9):571–82.

    Article  PubMed  Google Scholar 

  47. Heisler M, Hofer TP, Schmittdiel JA, Selby JV, Klamerus ML, Bosworth HB, et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial. Circulation. 2012;125(23):2863–72.

    Article  PubMed Central  PubMed  Google Scholar 

  48. Dey RM, de Vries MJ, Bosnic-Anticevich S. Collaboration in chronic care: unpacking the relationship of pharmacists and general medical practitioners in primary care. Int J Pharm Pract. 2011;19(1):21–9.

    Article  PubMed  Google Scholar 

  49. Guirguis K. The use of nonprescription medicines among elderly patients with chronic illness and their need for pharmacist interventions. Consult Pharm. 2010;25(7):433–9.

    Article  PubMed  Google Scholar 

  50. Santschi V, Chiolero A, Paradis G, Colosimo AL, Burnand B. Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care. 2012;35(12):2706–17.

    Article  PubMed Central  PubMed  Google Scholar 

  51. Aysola J, Bitton A, Zaslavsky AM, Ayanian JZ. Quality and equity of primary care with patient-centered medical homes: results from a national survey. Med Care. 2013;51(1):68–77.

    Article  PubMed Central  PubMed  Google Scholar 

  52. Kaldy J. Carving out the pharmacist’s role in the elusive ACO. Consult Pharm. 2012;27(3):165–70.

    Article  PubMed  Google Scholar 

  53. Jacobson PD, Jazowski SA. Physicians, the Affordable Care Act, and primary care: disruptive change or business as usual? J Gen Intern Med. 2011;26(8):934–7.

    Article  PubMed Central  PubMed  Google Scholar 

  54. Bernat JL. Ethical and quality pitfalls in electronic health records. Neurology. 2013;80(11):1057–61.

    Article  PubMed  Google Scholar 

  55. Miriovsky BJ, Shulman LN, Abernethy AP. Importance of health information technology, electronic health records, and continuously aggregating data to comparative effectiveness research and learning health care. J Clin Oncol. 2012;30(34):4243–8.

    Article  PubMed  Google Scholar 

  56. (ONC) OotNC. Advancements in technology are giving you tools and access to information to manage your health. 2012.

    Google Scholar 

  57. Walsworth DT. Medical apps: making your mobile device a medical device. Fam Pract Manag. 2012;19(3):10–3.

    PubMed  Google Scholar 

  58. Kabachinski J. Mobile medical apps changing healthcare technology. Biomed Instrum Technol. 2011;45(6):482–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. USF College of Pharmacy/USF Health, 12901 Bruce B. Downs Boulevard, MDC 30, Tampa, FL, 33612, USA

    Kevin B. Sneed Pharm.D., R.Ph.

Authors
  1. Kevin B. Sneed Pharm.D., R.Ph.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kevin B. Sneed Pharm.D., R.Ph. .

Editor information

Editors and Affiliations

  1. Cardiology, Tulane University School of Medicine, New Orleans, Louisiana, USA

    Keith C. Ferdinand

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sneed, K.B. (2015). Integration of a Team Approach to Hypertension Treatment. In: Ferdinand, K. (eds) Hypertension in High Risk African Americans. Clinical Hypertension and Vascular Diseases. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2010-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2010-5_13

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-2009-9

  • Online ISBN: 978-1-4939-2010-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation